Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03072628 · ClinicalTrials.gov registry record · NA
E-cigarettes, Nicotine Inhaler, and Blood Vessel Function
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 148
- Enrollment target
NCT03072628 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 148 participants.
The verdict
NCT03072628, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 148 participants
- Enrollment target
Study Summary
Randomized controlled trial of electronic cigarettes with nicotine, without nicotine, nicotine inhaler, and sham-control on endothelial function, oxidative stress and sympathetic nerve activity
Interventions
- OTHER sham control
- OTHER e-cig with nicotine
- OTHER e-cig without nicotine
- OTHER nicotine inhaler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2017-01-11 |
| Est. Completion | 2022-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03072628
The ClinicalTrials.gov registry entry for NCT03072628 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 148 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which sham control is the first listed.
NCT03072628 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03072628 about?
NCT03072628 is a clinical study titled "E-cigarettes, Nicotine Inhaler, and Blood Vessel Function". Randomized controlled trial of electronic cigarettes with nicotine, without nicotine, nicotine inhaler, and sham-control on endothelial function, oxidative stress and sympathetic nerve activity
What is the current status of trial NCT03072628?
This trial is currently completed. It is a NA study. The enrollment target is 148 participants. The study started on 2017-01-11. Estimated completion is 2022-12-01.
What interventions are being tested in trial NCT03072628?
The interventions under investigation include: sham control (OTHER), e-cig with nicotine (OTHER), e-cig without nicotine (OTHER), nicotine inhaler (OTHER).
Who is sponsoring clinical trial NCT03072628?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.